Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost

Abstract

Failing to control blood glucose levels within 'glycaemic goals', apart from the clinical consequences, can also have a significant financial impact, resulting in a 59.5% increase in the mean annual patient cost.